CLASS III Drug recall · Reported 28 Feb 2018 · FDA Enforcement Report
Calcium Acetate Capsules, 667 mg recalled by Nostrum Laboratories
Nostrum Laboratories is recalling Calcium Acetate Capsules, 667 mg per, distributed nationwide in the US. The recall was initiated on 13 Feb 2018 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0473-2018
- FDA event ID
- 79210
- Recalling firm
- Nostrum Laboratories, Kansas City, MO
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 13 Feb 2018
- FDA classified
- 20 Feb 2018
- Reported
- 28 Feb 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
Timeline
| 13 Feb 2018 | Recall initiated by company | |
| 20 Feb 2018 | Classified by FDA | +7 days |
| 28 Feb 2018 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Foreign Tablets/Capsules
Product as listed by the FDA
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Presence of Foreign Tablets/Capsules
Which lots are affected?
Lot: CAL173502; Exp. 09/19
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Nostrum Laboratories
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sucralfate Tablets recalled by Nostrum Laboratories | Nostrum Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Metformin Hydrochloride Extended-Release Tablets, USP 500 mg recalled | Nostrum Laboratories | Nitrosamine Impurity | Nationwide |
Other Calcium recalls
All 10| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Calcium Acetate Capsules 667 mg recalled by Cardinal HealthCalcium Acetate | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Calcium/ Cholecalciferol/ Sodium, Tablet, 600 mg//5 mg recalled | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Calcium Acetate, Capsule, 667 mg, Over The Counter recalled | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Calcium Acetate, Tablet, 667 mg, Over The Counter recalled | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Calcium Citrate, Tablet, 200 mg Elemental Calcium, Over The Counter recalled | Aidapak Services | Labeling Errors | 4 states |